OVERVIEW

The 2023 Symposium will focus on recent advances in the diagnosis, classification and management of patients with myelodysplastic syndromes (MDS). The program combines recent data, application of new tools and evidence on current practice with information that might be applied in the future.

LEARNING OBJECTIVES

Upon completion of the educational activity, participants should be able to:

• Identify and articulate the major challenges faced in the fields of diagnosis, prognosis, and therapy in MDS.
• Identify the key diagnostic criteria used in various MDS classification systems, including factors such as bone marrow morphology, cytogenetics, and clinical parameters.
• Assess the clinical implications of diagnosing pre-MDS states, including the need for regular monitoring, patient education, and informed decision-making regarding treatment options.
• Review the concept of lower-risk myelodysplastic syndromes (LR-MDS), including the clinical and hematological characteristics that define this subgroup.
• Explore various AI applications in MDS practice, such as risk stratification, diagnosis, treatment response prediction, and personalized treatment recommendations.
• Explore the importance of tailoring treatment approaches to individual patients, especially in the case of higher risk diseases.
• Review relevant clinical studies and trials that investigate the impact of cytoreduction on transplant outcomes.
• Utilize critical thinking skills to prioritize potential diagnoses, ruling them in or out systematically using clinical reasoning.

TARGET AUDIENCE

This activity is designed for an audience of pharmacists, physicians, physician assistants and nurses.

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and MDS Foundation. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 3.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.